Phase 1 Clinical Trials Program

The National Institutes of Health Roadmap for Medical Research calls for providing “the necessary foundation for advancing basic and clinical research” to speed promising therapies from the laboratory into the clinic for patient care. 

The Phase I Clinical Trials Program at Sylvester was created to fulfill this philosophy within a safe environment to provide patient care. The program is comprised of a multidisciplinary team of physicians, scientists, pharmacists, laboratory technicians, nurses, statisticians, research coordinators, and data managers with dedicated laboratory, pharmacy, and chemotherapy administration areas working together to provide the highest standard of care to patients who participate in Phase I trials.

Phase I trials are the first studies in humans, and, as a result, an important step to transition novel treatments from the bench to the bedside. The Phase I Clinical Trials Program assists physicians and scientists to establish important collaborative relationships that often translate into more treatment choices for patients.

The Phase I Clinical Trials Program at Sylvester is South Florida’s only academic phase I testing center dedicated to drug development for cancer patients.
Click here for a list of current Phase I trials by the program.